Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Akdogan

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Urologia Internationalis|September 14, 2007
Does age affect the prognosis of patients with testicular germ cell tumor?Kubilay Inci, Hasan Serkan Dogan, Bulent Akdogan, et al.
Clinical Genitourinary Cancer|March 10, 2012
Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinomaBulent Akdogan, Ahmet Gudeloglu, Kubilay Inci, et al.
Urologic Oncology|March 10, 2009
Presence of teratoma in orchiectomy specimen increases the need for postchemotherapy RPLNDKubilay Inci, Hasan Serkan Dogan, Bulent Akdogan, et al.
Clinical Genitourinary Cancer|October 16, 2012
Upper urinary tract transitional cell carcinoma: is there a best?Levent Mert Gunay, Bulent Akdogan, Artan Koni, et al.
The Journal of Urology|April 12, 2005
Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detectionSaadettin Yilmaz Eskicorapci, Fuad Guliyev, Bulent Akdogan, et al.
Journal of the National Medical Association|August 10, 2006
Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancerFadil Akyol, Ugur Selek, Gokhan Ozyigit, et al.
The Prostate|March 15, 2023
Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with <sup>177</sup> Lu-PSMA-617. A single-center prospective observational studyTugce Telli, Murat Tuncel, Erdem Karabulut, et al.
Urologic Oncology|January 18, 2026
High AST and the presence of liver metastases may guide for the need for FDG PET in advanced prostate cancer patientsTugce Telli, Murat Tuncel, Erdem Karabulut, et al.
The Journal of Urology|June 7, 2006
Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinomaBulent Akdogan, Hasan Serkan Dogan, Saadettin Yilmaz Eskicorapci, et al.
Ultrastructural Pathology|October 29, 2020
Primary ependymoma of the retropubic space in a male patientElif Tasar Kapakli, Kemal Kosemehmetoglu, Figen Kaymaz, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Urologia Internationalis|September 14, 2007
Does age affect the prognosis of patients with testicular germ cell tumor?Kubilay Inci, Hasan Serkan Dogan, Bulent Akdogan, et al.
Clinical Genitourinary Cancer|March 10, 2012
Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinomaBulent Akdogan, Ahmet Gudeloglu, Kubilay Inci, et al.
Urologic Oncology|March 10, 2009
Presence of teratoma in orchiectomy specimen increases the need for postchemotherapy RPLNDKubilay Inci, Hasan Serkan Dogan, Bulent Akdogan, et al.
Clinical Genitourinary Cancer|October 16, 2012
Upper urinary tract transitional cell carcinoma: is there a best?Levent Mert Gunay, Bulent Akdogan, Artan Koni, et al.
The Journal of Urology|April 12, 2005
Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detectionSaadettin Yilmaz Eskicorapci, Fuad Guliyev, Bulent Akdogan, et al.
Journal of the National Medical Association|August 10, 2006
Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancerFadil Akyol, Ugur Selek, Gokhan Ozyigit, et al.
The Prostate|March 15, 2023
Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with <sup>177</sup> Lu-PSMA-617. A single-center prospective observational studyTugce Telli, Murat Tuncel, Erdem Karabulut, et al.
Urologic Oncology|January 18, 2026
High AST and the presence of liver metastases may guide for the need for FDG PET in advanced prostate cancer patientsTugce Telli, Murat Tuncel, Erdem Karabulut, et al.
The Journal of Urology|June 7, 2006
Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinomaBulent Akdogan, Hasan Serkan Dogan, Saadettin Yilmaz Eskicorapci, et al.
Ultrastructural Pathology|October 29, 2020
Primary ependymoma of the retropubic space in a male patientElif Tasar Kapakli, Kemal Kosemehmetoglu, Figen Kaymaz, et al.
Pageof 5